What drove the intraday spike in SIGHT.PA stock?

Heavy trading and technical momentum drove the spike. Volume hit **5,991,097**, well above the 1,559,081 average. Traders reacted to pipeline momentum and the upcoming earnings date on 20 Mar 2026.

How does valuation look for SIGHT.PA stock?

Valuation is stretched: price-to-sales **18.50** and EV-to-sales **38.33** despite negative earnings. The company shows limited cash per share and a weak current ratio, increasing funding risk.

What are realistic near-term price levels for SIGHT.PA stock?

Short-term scenarios: a conservative downside target near **€0.07** and a bull target around **€0.18** if catalysts hit. Use tight risk controls given volatility.

Does Meyka AI provide a forecast for SIGHT.PA stock?

Yes. Meyka AI's forecast model projects a one-month level of **€0.08**, implying about **-30.67%** versus the current **€0.1154**. Forecasts are model-based and not guarantees.

EU Stocks

SIGHT.PA €0.1154 up 24% intraday on EURONEXT: heavy volume signals trader interest

ByHuzaifa Zahoor March 9, 2026

SIGHT.PA stock jumped 24.35% intraday to €0.1154 on EURONEXT on 09 Mar 2026 as volume surged to 5,991,097 shares. The move comes from a short-term technical squeeze around the 50-day average of €0.0881 and sharply higher relative volume versus the 1,559,081 average. Traders are watching pipeline news for GenSight Biologics S.A. and the March earnings calendar, with the company set to report on 20 Mar 2026.